These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9889028

  • 21. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5842-52. PubMed ID: 14676105
    [Abstract] [Full Text] [Related]

  • 22. Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I trial.
    Bell MC, Davidson SA, Mathis JM, Ampil F.
    Gynecol Oncol; 2001 Feb 01; 80(2):128-31. PubMed ID: 11161849
    [Abstract] [Full Text] [Related]

  • 23. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    Cancer and Leukemia Group B 89901Massachusetts General Hospital Cancer Center, Boston MA 02114, USA. dpryan@partners.org, Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, Goldberg RM, Mayer RJ.
    J Clin Oncol; 2006 Jun 01; 24(16):2557-62. PubMed ID: 16636336
    [Abstract] [Full Text] [Related]

  • 24. Combined hyperfractionated radiotherapy and protracted infusion chemotherapy in bladder cancer for organ preservation.
    Saracino B, Arcangeli G, Mecozzi A, Tirindelli Danesi D, Cruciani E, Altavista P, Giannarelli D.
    Clin Ter; 1998 Jun 01; 149(3):183-9. PubMed ID: 9842100
    [Abstract] [Full Text] [Related]

  • 25. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D, Gynecologic Oncology Group.
    Gynecol Oncol; 2006 Dec 01; 103(3):1038-42. PubMed ID: 16889823
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.
    Anticancer Res; 1999 Dec 01; 19(5C):4463-7. PubMed ID: 10650793
    [Abstract] [Full Text] [Related]

  • 29. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 30. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E, Omrcen T, Novaković ZS, Jelavić TB, Prskalo T, Hrepić D, Hamm W.
    Gynecol Oncol; 2006 Nov 01; 103(2):494-9. PubMed ID: 16814371
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
    Vokes EE, Moormeier JA, Ratain MJ, Egorin MJ, Haraf DJ, Mick R, Weichselbaum RR.
    Cancer Chemother Pharmacol; 1992 Nov 01; 29(3):178-84. PubMed ID: 1733549
    [Abstract] [Full Text] [Related]

  • 35. Brachytherapy and continuous infusion 5-fluorouracil for treatment of locally advanced, lymph node negative, prostate cancer: a phase I trial.
    See WA, Dreicer R, Wheeler JA, Forest PK, Loening S.
    Cancer; 1996 Mar 01; 77(5):924-7. PubMed ID: 8608485
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
    Salama JK, Haraf DJ, Stenson K, Milano MT, Witt ME, Vokes EE.
    Cancer J; 2005 Mar 01; 11(2):140-6. PubMed ID: 15969989
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
    Seiwert TY, Haraf DJ, Cohen EE, Stenson K, Witt ME, Dekker A, Kocherginsky M, Weichselbaum RR, Chen HX, Vokes EE.
    J Clin Oncol; 2008 Apr 01; 26(10):1732-41. PubMed ID: 18375903
    [Abstract] [Full Text] [Related]

  • 40. [Intraoperative radiotherapy for local recurrence of intrapelvic malignancies].
    Satake I, Tari K, Nakagomi K, Suda Y, Sekine T, Sakura M.
    Gan To Kagaku Ryoho; 1992 Aug 01; 19(10 Suppl):1690-2. PubMed ID: 1530333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.